NCT02572401

Brief Summary

African American men have by far the highest rates of HIV in the US, but there are few randomized controlled trials (RCTs) of interventions to dissuade heterosexually active African American men from engaging sexual risk behavior. This research seeks to address this gap in the behavioral intervention literature. That self-initiated behavior change, as well as intervention-induced behavior change, is often short-lived, eroding over time, is widely known; accordingly, this research also seeks to test a strategy to sustain intervention efficacy. In a RCT, African American men 18 to 45 years reporting recent unprotected intercourse with a woman will be randomized to the Steering Together in a New Direction (STAND) HIV Risk Reduction Intervention or a No-Intervention Control Condition. To test a strategy to sustain intervention effects, the men also will be randomized to receive or not receive individually tailored text messages. The theoretical basis of the interventions is social cognitive theory and the reasoned action approach, which is an extension of the theory of planned behavior and the theory of reasoned action. Men will complete self-report measures via audio computer-assisted self-interviewing at baseline and immediately post and 6 and 12 months post-intervention. The trial will test whether the STAND HIV Risk Reduction Intervention as compared with the No-Intervention Control Condition, increases consistent condom use, the primary outcome. Secondary outcomes include unprotected intercourse, multiple sexual partners, insertive anal intercourse, and proportion condom-protected intercourse. The trial will also test whether STAND's efficacy is greater among men in the Text Messaging Intervention compared with men not receiving text messages. This will provide information on the utility of a low-cost strategy to extend an intervention's efficacy. Finally, the study will test for mediation of intervention effects: the hypothesis that STAND affects outcome expectancies and self-efficacy, which, in turn, affect consistent condom use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
391

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2011

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 28, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 8, 2015

Completed
4 years until next milestone

Results Posted

Study results publicly available

October 15, 2019

Completed
Last Updated

October 15, 2019

Status Verified

October 1, 2019

Enrollment Period

1.7 years

First QC Date

September 28, 2015

Results QC Date

January 18, 2019

Last Update Submit

October 11, 2019

Conditions

Keywords

Human immunodeficiency virusSexually transmitted diseaseBehavioral interventionRandomized controlled trialText messagesSocial cognitive theoryTheory of planned behaviorSexual behaviorAfrican AmericansMen

Outcome Measures

Primary Outcomes (1)

  • Consistent (100%) Condom Use

    A binary variable reflecting whether or not the participant reports using a condom every time he had vaginal or anal intercourse with a woman in the previous 3 months. It will be based on a comparison of the number of protected intercourse acts and the number of intercourse acts. Men who report at least one intercourse act and whose number of reported protected acts equals their number of acts use condoms during 100% of intercourse acts and will be defined as practicing consistent condom use. Men who report at least one intercourse act and whose reported number of protected acts is less than their number of acts will be coded as not practicing consistent condom use. Separate binary variables reflect consistent condom use with steady partners and casual partners analyzed as a repeated outcome.

    Baseline, 6 months, 12 months post-intervention

Secondary Outcomes (4)

  • Unprotected Intercourse

    Baseline, 6 months, 12 months post-intervention

  • Multiple Partners

    Baseline, 6 months, 12 months post-intervention

  • Insertive Anal Intercourse

    Baseline, 6 months, 12 months post-intervention

  • Proportion Condom-protected Intercourse

    Baseline, 6 months, 12 months post-intervention

Study Arms (4)

HIV Risk Reduction Only

EXPERIMENTAL

STAND HIV Risk Reduction Intervention. Participants will not receive the Text Messaging Intervention.

Behavioral: STAND HIV Risk Reduction Intervention

No-Intervention No-Text Message Control

NO INTERVENTION

Participants do not receive the STAND HIV Risk Reduction Intervention or the Text Messaging Intervention.

HIV Risk Reduction and Text Messaging

EXPERIMENTAL

STAND HIV Risk Reduction Intervention and Text Messaging Intervention. Participants will receive the intervention and text messages.

Behavioral: STAND HIV Risk Reduction InterventionBehavioral: Text Messaging Intervention

Text Messaging Only

EXPERIMENTAL

Text Messaging Intervention. Participants will receive the text messages but not the STAND HIV Risk Reduction Intervention.

Behavioral: Text Messaging Intervention

Interventions

STAND HIV Risk Reduction Intervention, designed to increase consistent condom use and reduce other sexual risk behaviors, is implemented in small groups over 2 weekly 135-minute sessions. It draws on social cognitive theory, the reasoned action approach, and focus groups, a prospective survey, and an intervention pilot test with African American men. It contains culturally appropriate video clips, interactive activities, brainstorming, role-playing, and discussions designed to affect hypothesized mediators of risk-reducing behavior, including outcome expectancies about the effects of condom use on sexual enjoyment; self-efficacy and skill to have condoms available and to stop to use condoms or refuse unsafe sex even when aroused; and self-efficacy and skill to negotiate condom use.

Also known as: HIV Risk Reduction Intervention
HIV Risk Reduction OnlyHIV Risk Reduction and Text Messaging

Text Messaging Intervention participants receive text messages designed to increase the consistent use of condoms and to reduce other sexual risk behaviors. They receive 3 times a week text messages that ask about their sexual behavior and condom use that day and are asked to respond with either a 1 or 2 numeric response to indicate yes or no. Based on their responses, they receive either an affirming, pro safe-sex text message or a cautionary text against unprotected sex.

HIV Risk Reduction and Text MessagingText Messaging Only

Eligibility Criteria

Age18 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Ages 18 to 45 years
  • Self-identify as African American or Black
  • Born a male
  • Report having intercourse with a woman in the past 60 days without using a condom

You may not qualify if:

  • Report having intercourse with only 1 female partner in the past 60 days and being in a committed relationship with her for 6 or more months
  • Plan to relocate beyond a reasonable distance from the study in the next 18 months or do not have an address where he can receive mail
  • Report participating in an intervention research study on how to reduce HIV risks or negotiate safer sex in the previous 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeSexually Transmitted DiseasesSexual BehaviorMultiple Endocrine Neoplasia Type 1

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehaviorMultiple Endocrine NeoplasiaEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsNeoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesEndocrine System Diseases

Limitations and Caveats

The outcome measures are self-reported; hence, they may be biased by socially desirable responding or problems of memory. The participants were not randomly selected; hence the findings may not generalize to the target population.

Results Point of Contact

Title
Dr. John B. Jemmott III
Organization
University of Pennsylvania

Study Officials

  • John B Jemmott III, PhD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2015

First Posted

October 8, 2015

Study Start

October 1, 2011

Primary Completion

June 1, 2013

Study Completion

June 1, 2015

Last Updated

October 15, 2019

Results First Posted

October 15, 2019

Record last verified: 2019-10

Locations